{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    6,
    8,
    17,
    20,
    25,
    26,
    29,
    37,
    38,
    39
  ],
  "modelUsed": "gpt-5.1",
  "confidence": 1.0,
  "amendmentDetails": {
    "studyAmendmentImpacts": [
      {
        "id": "impact_1",
        "amendmentId": "amend_3_1_US",
        "affectedSection": "Overall Protocol (Amendment 3.1 (US))",
        "impactLevel": "Major",
        "instanceType": "StudyAmendmentImpact",
        "description": "Substantial amendment to clarify study procedures across different US sites, facilitate recruitment, and lessen participant inconvenience without compromising study quality"
      },
      {
        "id": "impact_2",
        "amendmentId": "amend_3_1_US",
        "affectedSection": "Section 1.3 - Schedule of Activities (SoA), Table 1 (footnote)",
        "impactLevel": "Minor",
        "instanceType": "StudyAmendmentImpact",
        "description": "Addition of footnote text to reference US-specific screening site procedures described in Section 8"
      },
      {
        "id": "impact_3",
        "amendmentId": "amend_3_1_US",
        "affectedSection": "Section 4.2 - Scientific Rationale for Study Design",
        "impactLevel": "Minor",
        "instanceType": "StudyAmendmentImpact",
        "description": "Adjustment of the post-discontinuation interval for zinc from 30 days to 21 days in the scientific rationale text"
      },
      {
        "id": "impact_4",
        "amendmentId": "amend_3_1_US",
        "affectedSection": "Section 8 - Study Assessments and Procedures",
        "impactLevel": "Major",
        "instanceType": "StudyAmendmentImpact",
        "description": "Addition of US-only text allowing certain US sites to conduct screening procedures only, without performing remaining on-study procedures"
      }
    ],
    "studyAmendmentReasons": [
      {
        "id": "reason_1",
        "amendmentId": "amend_3_1_US",
        "reasonText": "The main reason for preparation of this amendment was to clarify study procedures occurring across different sites in the US, so as to facilitate participant recruitment across different regions of the US, and to lessen inconvenience for participants without compromising the quality of the study.",
        "category": "Operational",
        "isPrimary": true,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_2",
        "amendmentId": "amend_3_1_US",
        "reasonText": "Addition of text to the Schedule of Activities footnote to state that procedures specific to US screening sites are detailed in Section 8, to keep the SoA aligned with the more detailed procedural description.",
        "category": "Operational",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_3",
        "amendmentId": "amend_3_1_US",
        "reasonText": "To align the number of days with the mention of zinc discontinuation elsewhere in the protocol.",
        "category": "Scientific",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_4",
        "amendmentId": "amend_3_1_US",
        "reasonText": "To facilitate participant recruitment across different regions of the US and to lessen inconvenience for participants without compromising the quality of the study.",
        "category": "Operational",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      }
    ],
    "studyChanges": [
      {
        "id": "change_1",
        "amendmentId": "amend_3_1_US",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "1.3",
        "beforeText": "Schedule of Activities (SoA), Table 1 footnote text (exact prior footnote content not provided in the excerpt) did not reference Section 8 for US-only screening site procedures.",
        "afterText": "Footnote to Table 1 includes added text stating that procedures specific to screening sites (only in the US) are detailed in Section 8.",
        "summary": "Added SoA footnote language indicating that US screening-siteâ€“specific procedures are described in Section 8, to cross-reference newly added operational options for US screening-only sites."
      },
      {
        "id": "change_2",
        "amendmentId": "amend_3_1_US",
        "changeType": "Modification",
        "instanceType": "StudyChange",
        "sectionNumber": "4.2",
        "beforeText": "However, the physiologic turnover of human gastrointestinal epithelial cells is 3 - 5 days (Darwich, 2014); therefore, the inhibitory effect of zinc on intestinal copper absorption is expected to be minimal 30 days after discontinuation of zinc.",
        "afterText": "However, the physiologic turnover of human gastrointestinal epithelial cells is 3 - 5 days (Darwich, 2014); therefore, the inhibitory effect of zinc on intestinal copper absorption is expected to be minimal 21 days after discontinuation of zinc.",
        "summary": "Changed the post-zinc discontinuation interval in the scientific rationale from 30 days to 21 days to align with other protocol references to zinc washout duration."
      },
      {
        "id": "change_3",
        "amendmentId": "amend_3_1_US",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "8",
        "beforeText": "Section 8 contained study assessments and procedures but did not specify that some US sites could function solely as screening sites, performing only screening procedures.",
        "afterText": "Section 8 includes additional text applicable only to the US that details the possibility for sites in the US to only perform screening procedures and not any of the remaining study procedures.",
        "summary": "Added US-only operational language to allow designated US sites to act as screening-only locations, with all non-screening study procedures conducted elsewhere."
      }
    ],
    "summary": {
      "impactCount": 4,
      "reasonCount": 4,
      "changeCount": 3
    }
  }
}